Disclosed is the therapeutic potential of Calebin A for osteoporosis (boneloss) caused byaging or chronic disease conditions like cancer. Calebin A is shown to downmodulateosteoclastogenesis induced by receptor activator of nuclear factor (NF)-.kappa.B ligand(RANKL) signalling thereby having therapeutic potential for osteoporosis.